PSIAC

Literaturverzeichnis


Vergara-López S. Med Clin (Barc). Nov 2004; 123(16): 639 Pubmed [5810]
Verhagen CA. Br J Clin Pharmacol. Feb 1994; 37(2): 193-7 Pubmed [5469]
Vermeir M. Drug Metab Dispos. Apr 2008; 36(4): 769-79 Pubmed [245]
Vermeir M. Drug Metab Dispos. Apr 2009; 37(4): 809-20 Pubmed [4217]
Vermes A. Am J Cardiovasc Drugs. Jan 2004; 4(4): 247-55 Pubmed [205]
Vermes A. J Antimicrob Chemother. Aug 2000; 46(2): 171-9 Pubmed [7338]
Vernon C. Br J Clin Pract. Apr 1979; 33(4): 112, 121 Pubmed [3266]
Veronese ML. J Clin Pharmacol. Aug 2003; 43(8): 831-9 Pubmed [1878]
Verpooten GA. Br J Clin Pharmacol. Aug 1984; 18(2): 183-93 Pubmed [7566]
Verpooten GA. Br J Clin Pharmacol. Aug 1991; 32(2): 187-92 Pubmed, Volltext [4264]
Verrando R. Acta Gastroenterol Belg. Jan 2005; 68(1): 81-5 Pubmed [3459]
Veselinović T. Psychopharmacology (Berl). May 2015; 232(9): 1607-17 Pubmed [4338]
Vestal RE, Kornhauser DM, Hollifierld JW, Shand DG. Inhibition of propanolol metabolism by chlorpromazine. Clin pharmacol Ther (1979) 25, 19-25 [922]
Vestri et al. (2007) Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacol 32:765-772 [2783]
Vethe NT. Tidsskr Nor Laegeforen. Oct 2011; 131(20): 2000-3 Pubmed [7434]
Vetter PH, Proppe DG. Clozapine induced coma. J Nerv Ment Dis (1992) 180, 58-9 [1052]
Vevelstad M. Eur J Clin Pharmacol. Aug 2009; 65(8): 795-801 Pubmed [405]
vgl. auch Literatur zur Interaktion von Clozapin mit Benzodiazepinen [1963]
Viani F. Eur J Pediatr. Sep 1992; 151(9): 715 Pubmed [5991]
Vickers AE. Drug Metab Dispos. Sep 1999; 27(9): 1029-38 Pubmed [213]
Vidal X. Drug Saf. Jan 2008; 31(2): 159-68 Pubmed [998]
Vieira ML. Clin Pharmacol Ther. Apr 2012; 91(4): 700-8 Pubmed [6538]
Vieta E. J Affect Disord. Aug 2008; 109(3): 251-63 Pubmed [3891]
Vieweg WV. Drugs Aging. Jan 2009; 26(12): 997-1012 Pubmed [2631]
Vieweg WV. Ther Adv Infect Dis. Aug 2013; 1(4): 121-38 Pubmed [5322]
Vigneault P. Eur J Pharmacol. Apr 2012; 681(1-3): 68-74 Pubmed [3968]
Vigneault P. J Cardiovasc Pharmacol. Jun 2011; 57(6): 690-5 Pubmed [2630]
Vihavainen T. J Neurochem. Nov 2008; 107(3): 844-54 Pubmed [4167]
Vijayaraghavan S. Nat Commun. Jun 2017; 8: 15916 Pubmed [7539]
Vila A. Scand J Infect Dis. Jan 2001; 33(10): 788-9 Pubmed [6438]
Villikka K. Br J Clin Pharmacol. May 1997; 43(5): 471-4 Pubmed [6205]
Villikka K. Clin Pharmacol Ther. Apr 1999; 65(4): 377-81 Pubmed [6202]
Villikka K. Clin Pharmacol Ther. Dec 1997; 62(6): 629-34 Pubmed [6204]
Villikka K. Clin Pharmacol Ther. Dec 1999; 66(6): 589-93 Pubmed [781]
Villikka K. Clin Pharmacol Ther. Jan 1997; 61(1): 8-14 Pubmed [6257]
Vinceneux P. Int J Clin Pharmacol Ther Toxicol. Mar 1986; 24(3): 153-8 Pubmed [3569]
Vincent FM. Ann Intern Med. Jul 1980; 93(1): 56-7 Pubmed [652]
Vincent J. Br J Clin Pharmacol. Nov 2000; 50(5): 455-63 Pubmed, Volltext, DOI [3815]
Vincent SH. Drug Metab Dispos. Apr 2007; 35(4): 533-8 Pubmed [4324]
Viramontes TS. Consult Pharm. Mar 2016; 31(3): 139-50 Pubmed [4996]
Vispo E. Antivir Ther. Jan 2008; 13(3): 429-37 Pubmed [6703]
Vitali M. J Clin Psychopharmacol. Feb 2013; 33(1): 95-8 Pubmed [4874]
Vlase L. Eur J Drug Metab Pharmacokinet. Jan 2011; 35(3-4): 83-7 Pubmed [5846]
Vobra SB. Convulsions after enflurane in a schizophrenic patient receiving neuroleptics. Can J Anaesth (1994) 41, 420-2 [864]
Vogel M. Liver Transpl. Jul 2004; 10(7): 939-44 Pubmed [6488]
Vogelman et al. Neuropsychopharmacol 1999;20:480-490 [3135]
Voican CS. Am J Psychiatry. Apr 2014; 171(4): 404-15 Pubmed [3898]
Volans A. BMJ Case Rep. Jan 2013; 2013 Pubmed, Volltext, DOI [4033]
Voll ML. Pharm World Sci. Oct 2010; 32(5): 575-80 Pubmed [3671]
Volpi-Abadie J. Ochsner J. Jan 2013; 13(4): 533-40 Pubmed, Volltext [18]
von Moltke et al. J Pharm Sci. 1998 Oct;87(10):1184-9 [1234]
von Moltke LL. Biol Psychiatry. Feb 1997; 41(3): 377-80 Pubmed [3738]
von Moltke LL. Br J Clin Pharmacol. Jul 1994; 38(1): 23-31 Pubmed, Volltext [1331]
Von Moltke LL. Br J Clin Pharmacol. Jul 1999; 48(1): 89-97 Pubmed, Volltext, DOI [234]
von Moltke LL. Drug Metab Dispos. Aug 2001; 29(8): 1102-9 Pubmed [118]
von Moltke LL. J Clin Pharmacol. Dec 1994; 34(12): 1222-7 Pubmed [1881]
von Moltke LL. J Clin Pharmacol. Jan 2001; 41(1): 85-91 Pubmed [4636]
von Moltke LL. J Clin Pharmacol. Sep 1996; 36(9): 783-91 Pubmed [1874]
von Moltke LL. J Clin Psychopharmacol. Apr 1996; 16(2): 104-12 Pubmed [5884]
von Moltke LL. J Pharm Pharmacol. Sep 1998; 50(9): 997-1004 Pubmed [4503]
von Moltke LL. J Pharm Sci. Oct 1998; 87(10): 1184-9 Pubmed [4989]
von Moltke LL. J Pharmacol Exp Ther. Mar 1994; 268(3): 1278-83 Pubmed [377]
von Richter O. Clin Pharmacokinet. Jan 2007; 46(7): 613-22 Pubmed [3249]
von Rosensteil NA. Drug Saf. Aug 1995; 13(2): 105-22 Pubmed [5321]
von Rosenstiel P. Neurotherapeutics. Jan 2007; 4(1): 84-7 Pubmed [330]
Voorman RL. Drug Metab Dispos. Jan 2001; 29(1): 41-7 Pubmed [4471]
Vorspan F. Am J Addict. Sep 2010; 19(5): 458-9 Pubmed [3220]
Vosse-Matagne G. Acta Gastroenterol Belg. Jul 1975; 38(7-8): 249-59 Pubmed [6106]
Vourvahis M. Clin Pharmacol Drug Dev. May 2014; 3(3): 202-6 Pubmed [6871]
Waade RB. Ther Drug Monit. Apr 2009; 31(2): 233-8 Pubmed [45]
Wade AG. Psychol Med. Oct 2011; 41(10): 2089-97 Pubmed [7530]
Wadhani N. J Cardiovasc Pharmacol Ther. Sep 2006; 11(3): 184-90 Pubmed [3723]
Wagner F, Kalusche D, Trenk D, Jähnchen E, Roskamm H. Drug interaction between propafenine and metoprolol Br J Clin Pharmacol. 1987 Aug;24(2):213–220 [2979]
Wagner J. J Neurol. Jul 2009; 256(7): 1182-3 Pubmed [3735]
Wagner J. Pediatrics. May 2015; 135(5): e1333-6 Pubmed [7079]
Wagner, Vause. Clin Pharmacokinet (1995) 29 (Suppl 1), 26-32 [1496]
Wahawisan J. Ann Pharmacother. Jun 2011; 45(6): e34 Pubmed [3313]
Wahlang B. Adv Pharmacol. Jan 2015; 74: 1-33 Pubmed [334]
Wakeham K. J Antimicrob Chemother. Feb 2010; 65(2): 316-9 Pubmed [7154]
Wakelee HA. Cancer Chemother Pharmacol. Feb 2012; 69(2): 563-71 Pubmed [368]
Wakisaka S. Fukuoka Igaku Zasshi. Apr 1990; 81(4): 192-6 Pubmed [2143]
Walder A. Acta Medica (Hradec Kralove). Jan 2009; 52(1): 15-8 Pubmed [3237]
Walder A. Pharmacopsychiatry. Mar 2009; 42(2): 79-81 Pubmed [4117]
Waldschmitt C, Eckermann G, Hiemke C. Das pharmakokinetische Interaktionspotenzial von Duloxetin im Vergleich mit dem von anderen neuen Antidepressiva. Psychopharmakotherapie (PPT)(2009) 16:14-18 [4063]
Waldschmitt C, Hiemke C, Eckermann G (2009)Das pharmakokinetische Interaktionspotenzial von Duloxetin im Vergleich mit dem von anderen neuen Antidepressiva, Psychopharmakotherapie 16:14-18 [2715]
Waldschmitt et al. Psychopharmakotherapie 2009;16:14-18 [3058]
Walimbwa SI. Antimicrob Agents Chemother. Jan 2019; 63(2) Pubmed [6646]
Walker DK. Drug Metab Dispos. Apr 1996; 24(4): 447-55 Pubmed [4006]
Walker J. J Am Dent Assoc. Dec 1979; 99(6): 995-6 Pubmed [5975]
Walker R. Clin Transplant. Sep 2008; 22(5): 594-602 Pubmed [3158]
Walker UA. J HIV Ther. May 2003; 8(2): 32-5 Pubmed [6700]
Wallace DF. Clin Biochem Rev. May 2016; 37(2): 51-62 Pubmed [7253]
Wallace RJ Jr. J Infect Dis. Mar 1995; 171(3): 747-50 Pubmed [6758]
Wallace S. Br J Clin Pharmacol. Apr 1976; 3(2): 327-30 Pubmed [7606]
Walley T. Lancet. Apr 1993; 341(8850): 967-8 Pubmed [1364]
Walsh E. Br J Psychiatry. May 2002; 180: 466 Pubmed [3581]
Walsh R. Biochim Biophys Acta. Dec 2011; 1810(12): 1230-5 Pubmed, Volltext, DOI [3969]
Walsky RL. J Clin Pharmacol. Dec 2006; 46(12): 1426-38 Pubmed [2699]
Walsky RL. J Clin Pharmacol. Jan 2005; 45(1): 68-78 Pubmed [373]
Walters. J Am Acad Child Adolesc Psychiatry (1992) 31, 565-566 [1374]